Research.Patient.info
Metastatic triple negative breast cancer research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
Molecular PD-L1 PET/CT Imaging with 89Zr-atezolizumab to Monitor Immune Responses in metastatic Triple Negative Breast Cancer
This study looks at a new way to scan for breast cancer using a special dye and a PET/CT scan. It compares this new scan with a standard test to see how well they match. The goal is to better understand and treat advanced triple-negative breast cancer.
Sweden - active not recruitingPHASE2
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
This study looks at new ways to treat an aggressive type of breast cancer called triple-negative breast cancer (TNBC). It compares Olaparib alone to Olaparib combined with other drugs, aiming to find safer, more effective treatments, especially for those with specific genetic changes.
United States · Belgium · Canada